InvestorsHub Logo
icon url

$heff

07/28/09 2:00 AM

#15242 RE: Investor100 #15158

Investor100...will be keeping a close eye on TSPT come first week in August! Thanks for the heads up on that one.
icon url

Investor100

08/03/09 9:01 PM

#15608 RE: Investor100 #15158

Beast @ TSPT

Expected this one to sleep until early Fall due in part to delay by the FDA ...did not happen!

http://stockcharts.com/charts/gallery.html?s=tspt

Up $2.37 / +40.51%

Transcept Pharmaceuticals Inc. (TSPT: 8.22, 2.37, 40.51%)
Transcept announced an exclusive license with Purdue Pharmaceuticals to commercialize Intermezzo, a sleep aid for treating Insomnia in the United States. If approved by the U.S. Food and Drug Administration (FDA: undefined, undefined, undefined%), Intermezzo could be first prescription sleep aid approved for use in the middle of the night when a patient awakens and cannot fall back asleep. Shares surged 33.6% in pre-market trading.

Investor 100